A Novel Nomogram for Predicting Risk Factors and Outcomes in Bloodstream Infections Caused by Klebsiella pneumoniae

References

• Wyres KL, Lam MMC, Holt KE. Population genomics of Klebsiella pneumoniae. Nat Rev Microbiol. 2020;18(6):344–359.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Pfaller MA, Jones RN, et al. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. Int J Antimicrob Agents. 2000;13(4):257–271.
   Web of Science ®Google Scholar
• Diekema DJ, Hsueh PR, Mendes RE, et al. The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother. 2019;63(7):e00355–19.
   PubMed Web of Science ®Google Scholar
• Pan H, Lou Y, Zeng L, et al. Infections Caused by Carbapenemase-producing Klebsiella pneumoniae: microbiological Characteristics and Risk Factors. Microb Drug Resist. 2019;25(2):287–296.
   Web of Science ®Google Scholar
• Shilo S, Assous MV, Lachish T, et al. Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study. Infection. 2013;41(2):503–509.
   PubMed Web of Science ®Google Scholar
• Debby BD, Ganor O, Yasmin M, et al. Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit. Eur J Clin Microbiol Infect Dis. 2012;31(8):1811–1817.
   Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100, 30th Edition. Available from: http://www.clsi.org/. Accessed January 2020..
   Google Scholar
• Food and Drug Administration. Antibacterial Susceptibility Test Interpretive Criteria. Available from: https://www.fda.gov/drugs/development-resources/antibacterial-susceptibility-test-interpretive-criteria. Accessed October 2021.
   Google Scholar
• Serenari M, Han KH, Ravaioli F, et al. A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma. J Hepatol. 2020;73(4):855–862.
   PubMed Web of Science ®Google Scholar
• Xiao T, Yu W, Niu T, et al. A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infections: tigecycline significantly increases the mortality. Infect Drug Resist. 2018;11:595–606.
   PubMed Web of Science ®Google Scholar
• Orsi GB, García-Fernández A, Giordano A, et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect. 2011;78(1):54–58.
   PubMed Web of Science ®Google Scholar
• Patel G, Huprikar S, Factor S, et al. Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infection and the Impact of Antimicrobial and Adjunctive Therapies. Infect Control Hospital Epidemiol. 2008;29(12):1099–1106.
   PubMed Web of Science ®Google Scholar
• Thapa S, Min L, Hui X, et al. Acetylcholinesterase: a Primary Target for Drugs and Insecticides. Mini Rev Med Chem. 2017;17(17):1665–1676.
   Web of Science ®Google Scholar
• Zhang H, Guo Z, Chai Y, et al. Risk Factors for and Clinical Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Nosocomial Infections: a Retrospective Study in a Tertiary Hospital in Beijing, China. Infect Drug Resist. 2021;14:1393–1401.
   Web of Science ®Google Scholar
• Wang Q, Zhang Y, Yao X, et al. Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections. Eur J Clin Microbiol Infect Dis. 2016;35(10):1679–1689.
   PubMed Web of Science ®Google Scholar
• Cai Y, Wang R, Liang B, et al. Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of Infectious disease. Antimicrob Agents Chemother. 2011;55(3):1162–1172.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Drug safety announcement–tigecyclin. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm369580.htm. Accessed September 2015.
   Google Scholar
• Ni W, Han Y, Liu J, et al. Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: a Systematic Review and Meta-Analysis. Medicine. 2016;95(11):e3126.
   PubMed Web of Science ®Google Scholar
• Wu Q, Ren J, Wang G, et al. The Incidence, Clinical Outcomes, and Risk Factors of Thrombocytopenia in Intra-Abdominal Infection Patients: a Retrospective Cohort Study. PLoS One. 2016;11(1):e0147482.
   Web of Science ®Google Scholar
• Wang Z, Ren J, Liu Q, et al. Hypermucoviscous Klebsiella pneumoniae infections induce platelet aggregation and apoptosis and inhibit maturation of megakaryocytes. Thromb Res. 2018;171:45–54.
   PubMed Web of Science ®Google Scholar
• Guo C, Yuan L, Wang JG, et al. Lipopolysaccharide (LPS) induces the apoptosis and inhibits osteoblast differentiation through JNK pathway in MC3T3-E1 cells. Inflammation. 2014;37(2):621–631.
   PubMed Web of Science ®Google Scholar
• Fan WJ, Li HP, Zhu HS, et al. NF-κB is involved in the LPS-mediated proliferation and apoptosis of MAC-T epithelial cells as part of the subacute ruminal acidosis response in cows. Biotechnol Lett. 2016;38(11):1839–1849.
   Web of Science ®Google Scholar
• Catani L, Fagioli ME, Tazzari PL, et al. Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes. Exp Hematol. 2006;34(7):879–887.
   Web of Science ®Google Scholar
• Leytin V, Mykhaylov S, Starkey AF, et al. Intravenous immunoglobulin inhibits anti-glycoprotein IIb-induced platelet apoptosis in a murine model of immune thrombocytopenia. Br J Haematol. 2006;133(1):78–82.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Wang J, Yao Z, et al. Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections and Outcomes. Infect Drug Resist. 2020;13:207–215.
   Web of Science ®Google Scholar